OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.
The company’s first product- the InSpace™ System is indicated for Rotator Cuff syndrome as it alleviates pain in patients. The InSpace™ System has the CE mark and is commercially available in Europe.
In the USA, the InSpace is an investigational device. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigations.
|Employees (est.) (Sept 2020)||25|
OrthoSpace total Funding
OrthoSpace latest funding size
Time since last funding
|4 years ago|
|TriVentures, Johnson & Johnson Innovation, HealthpointCapital, Smith & Nephew|
When was OrthoSpace founded?
OrthoSpace was founded in 2009.
Who are OrthoSpace key executives?
OrthoSpace's key executives are Itay Barnea, Assaf Dekel and Heather Neill.
How many employees does OrthoSpace have?
OrthoSpace has 25 employees.
Who are OrthoSpace competitors?
Competitors of OrthoSpace include TGR Biosciences, Verax Biomedical and InoCardia.
Where is OrthoSpace headquarters?
OrthoSpace headquarters is located at 7 Khalamish St, Caesarea.
Where are OrthoSpace offices?
OrthoSpace has offices in Caesarea, Macquarie Park, Viriat, Kiel and in 10 other locations.
How many offices does OrthoSpace have?
OrthoSpace has 14 offices.
Receive alerts for 300+ data fields across thousands of companies